Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation

Published:2018-03-25 Issue:3 Volume:20 Page:e12878
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Kabulski Galen M.¹²,MacVane Shawn H.¹³^ORCID

Affiliation:

1. Department of Pharmacy Services; Medical University of South Carolina; Charleston SC USA

2. Medical University of South Carolina College of Pharmacy; Charleston SC USA

3. Division of Infectious Diseases; Department of Medicine; Medical University of South Carolina; Charleston SC USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12878/fullpdf

Reference18 articles.

1. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients;Billaud;Med Mycol,2010

2. Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients;Han;Antimicrob Agents Chemother,2010

3. Isavuconazole: a new broad-spectrum triazole antifungal agent;Miceli;Clin Infect Dis,2015

4. Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent;Rybak;Pharmacotherapy,2015

5. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries;Verweij;J Chemother,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients;Transplant International;2023-12-15

2. Antifungal Prophylaxis After Lung Transplantation: Where Are We Now?;Transplantation;2021-11-22

3. Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients;Journal of Fungi;2021-01-22

4. Isavuconazole—Animal Data and Clinical Data;Journal of Fungi;2020-10-06

5. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis;Pediatric Pulmonology;2020-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3